Arcturus Therapeutics Holdings Inc. - Common stock, par value $0.001 per share (ARCT)

Q: What does CUSIP 03969T109 represent in this 13F holders report?

CUSIP 03969T109 is the security identifier for ARCT - Arcturus Therapeutics Holdings Inc. - Common stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held ARCT - Arcturus Therapeutics Holdings Inc. - Common stock, par value $0.001 per share in Q3 2022?

106 institutional investors reported ARCT - Arcturus Therapeutics Holdings Inc. - Common stock, par value $0.001 per share for Q3 2022. Use the holders table for investor-level position and value details.

CUSIP: 03969T109

Q3 2022 13F Holders as of 30 Sep 2022

Security type / class: Equity / Common stock, par value $0.001 per share
Total 13F shares: 22,166,410
Total 13F value: $328,065,176
Share change: -83,181
Put/Call ratio: 53%
SEC-reported price per share: $14.82
Number of holders: 106
Value change: -$1,828,982
Number of buys: 46
Number of sells: 61
Shares outstanding: 28,628,932

Security key

03969T109

Report period

Q3 2022

Institutions

106

Top holders

ARCT full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Arcturus Therapeutics Holdings Inc. SEC filings Arcturus Therapeutics Holdings Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 03969T109

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of ARCT - Arcturus Therapeutics Holdings Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FEDERATED HERMES, INC.

Disclosed value leader

FEDERATED HERMES, INC.

Comparable rows

0/15

Latest evidence

30 Jun 2022

13F 3/4/5 Highest disclosed value: $56,052,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FEDERATED HERMES, INC. has the largest disclosed position value at $56.05M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FEDERATED HERMES, INC.'s linked filing trail.

Disclosed position value Top 5

FEDERATED HERMES, INC. $56.05M

ARK Investment Management LLC $45.8M

STATE STREET CORP $44.18M

BlackRock Finance, Inc. $29.97M

Ultragenyx Pharmaceutical Inc. $26.21M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FEDERATED HERMES, INC.	13F Company 13F	— denominator unverified	$56,052,000 3,561,097 shares	—	30 Jun 2022
ARK Investment Management LLC	13F Company 13F	— denominator unverified	$45,799,000 2,303,751 shares	—	30 Jun 2022
STATE STREET CORP	13F Company 13F	— denominator unverified	$44,181,000 2,806,918 shares	—	30 Jun 2022
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$29,973,000 1,904,302 shares	—	30 Jun 2022
Ultragenyx Pharmaceutical Inc.	3/4/5 Director 3/4/5	— denominator unverified	$26,208,420 1,400,000 shares	—	10 Aug 2021
Sumitomo Mitsui Trust Group, Inc.	13F Company 13F	— denominator unverified	$22,606,000 1,436,194 shares	—	30 Jun 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

106

22,166,410

Rows available

106

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

116

Q3 2022 holders

106

Holder diff

-10

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 value	Q3 2022 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend